<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860596</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1579</article-id><article-id pub-id-type="other">EPV0992</article-id><article-id pub-id-type="pii">S0924933824015797</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Haloperidol induced Pisa syndrome in a patient with treatment resistant schizophrenia</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Yaich</surname><given-names>I.</given-names></name><xref rid="aff3425" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3426" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor1428" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Touiti</surname><given-names>A.</given-names></name><xref rid="aff3425" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3426" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ben Said</surname><given-names>C.</given-names></name><xref rid="aff3425" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3426" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bram</surname><given-names>N.</given-names></name><xref rid="aff3425" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3426" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff3425"><sup>1</sup>Forensic Psychiatry Departement, <institution>Razi Hospital</institution>, <city>La Manouba</city></aff><aff id="aff3426"><sup>2</sup>Faculty of Medecine of Tunis, <institution>Tunis El Manar University</institution>, <city>Tunis</city>, <country>Tunisia</country></aff><author-notes><corresp id="cor1428"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1554">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S759</fpage><lpage>S759</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824015797a.pdf"/><abstract><sec id="sec8584"><title>Introduction</title><p>Acute dystonia, an adverse effect of neuroleptics, is linked to D2 neuronal receptor hypersensitivity or neurotoxicity due to oxidative stress mechanisms. Pisa syndrome (PS) or Pleurothotonus, a relatively uncommon condition, manifests as dystonia of the trunk and is potentially reversible with early intervention.</p></sec><sec id="sec8585"><title>Objectives</title><p>To describe PS following haloperidol decanoate injection in a treatment-resistant schizophrenia (TRS) patient, identify associated risk factors, and present therapeutic options.</p></sec><sec id="sec8586"><title>Methods</title><p>We provide a comprehensive case description and perform a PubMed database search using the following keywords: &#x0201c;Pisa syndrome,&#x0201d; &#x0201c;dystonia,&#x0201d; &#x0201c;schizophrenia,&#x0201d; and &#x0201c;antipsychotic&#x0201d;.</p></sec><sec id="sec8587"><title>Results</title><p>A 54-year-old man with TRS, previously treated with 100 mg of haloperidol decanoate and 10 mg of olanzapine due to clozapine-induced myocarditis, exhibited hallucinatory delusional syndrome and behavioral disturbances. Neurological examination, lab tests, and brain imaging confirmed a psychotic relapse. Haloperidol decanoate dosage was increased to 150 mg. Four days later, the patient developed a trunk tilt that resolved after receiving anticholinergic treatment.Despite PS being more common in females and associated with brain conditions, this patient presented multiple risk factors, including prolonged typical antipsychotic treatment, advanced age, and an increase in antipsychotic doses. Discontinuing the causative antipsychotic or adding synthetic anticholinergics led to symptom reversibility.</p></sec><sec id="sec8588"><title>Conclusions</title><p>PS is a rare occurrence. Understanding associated risk factors and frequently implicated medications is crucial for elucidating the phenomenon and managing the disorder</p></sec><sec id="sec8589"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>